AI assistant
DEXCOM INC — Director's Dealing 2025
Jun 17, 2025
30198_dirs_2025-06-17_32061f09-753b-4502-ba41-1e2ee68bd930.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2025-06-13
Reporting Person: AUGUSTINOS NICHOLAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-13 | Common Stock | S | 2618 | $81.69 | Disposed | 37083 | Indirect |
| 2025-06-16 | Common Stock | S | 3672 | $82.80 | Disposed | 33411 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5046 | Direct |
Footnotes
F1: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee.
F3: Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.